Sign in
IXSBF Stock Price, Chart, Stats & News
InNexus Biotechnology, Inc.
Save
InNexus Biotechnology, Inc. (IXSBF) does not currently pay a dividend.
12,627
Market cap
–
Current P/E
–
Forward P/E
IXSBF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Pharmaceuticals
Industry
InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties.
Similar securities
Based on sector and market capitalization
Report issue